Article Figures & Data
Figures
- Figure 1.
Biomarker Profile of Heart Failure
Reproduced from Braunwald E. State-of-the-Art Paper: Heart Failure. JACC: Heart Failure 2013;1(1)1–20. With permission from Elsevier.
- Figure 2.
Expression of MiR-499 in Humans
HF=heart failure; LVAD=left ventricular assist devices.
Reproduced from Matkovich SJ et al. Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy. Circ Res 2012 Aug 17;111(5):521–31. With permission from Lippincott Williams and Wilkins.
- Figure 3.
Cardiac Myosin Activation in Patients With HFrEF
HFrEF=heart failure with reduced ejection fraction; LVEDV=left ventricular end-diastolic volume; LVESV=left ventricular end-systolic volume; SET= systolic ejection time; SV=systolic volume.
Reproduced from Cleland 1G et al. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet 2011; 378(9792):676–683. With permission from Elsevier.
- Figure 4.
Survival: Post Explantation/Transplantation
BTR=bridge to recovery; BTT=bridge to transplant.
Reproduced from Birks EJ et al. Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation. J Thorac Cardiovasc Surg 2012; 144(1):190–196. With permission from Elsevier.
Tools
Table of contents
Cited By...
- No citing articles found.